MDL-28161

N/A

Report date: 2023/02/15 14:12:40
NME

Base Information

Drug NameMDL-28161
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonists
TargetsSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis
Active IndicationsN/A
Inactive IndicationsPsychotic Disorders

Other Information

ATC CodeN/A
Related LinksN/A